¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"HCV PCR viral detection test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® test ÇÑ±Û °Ë»ç
¼³¸í   
  ¾î¶² ´Ù¸¥ ¹°ÁúÀ» °ËÃâ, ÃøÁ¤, »ý¼ºÇϱâ À§ÇѠƯÁ¤ÇÑ È­ÇйÝÀÀÀ» ÀÏÀ¸Å°´Âµ¥ »ç¿ëµÇ´Â ¹æ¹ý.
¿µ¹® scratch test ÇÑ±Û ³­Àý¹ý
¼³¸í   
  ÇǺθ¦ ³¯Ä«·Î¿î ¹Ù´Ã·Î ±Ü¾î ÇǺÎÀÇ ¹ÝÀÀÀ» º¸´Â °Ë»ç·Î ÇǺΠ°ú¹Î¹ÝÀÀÀ̳ª ¾Ë·¹¸£±â¸¦ ¾Ë¾Æº¸±â À§ÇÑ °Ë»çÀÌ´Ù. ¹Ù´Ã³¡¿¡ Ç׿øÀ» ¹¯Èù µÚ, ÇǺιØÀ» ±Ü¾î ¹ÝÀÀÀ» ¾Ë¾Æº»´Ù. À̶§ Ç׿øÀÌ ¾Æ´Ñ ´ëÁ¶¹°Áú(¿¹¸¦ µé¾î º¸ÅëÀÇ ¹°)À» ¹¯Èù ¹Ù´ÃÀ» °°ÀÌ ¹ÝÀÀÇÏ¿© ÇǺ馱âÁõ(dermographism) ´ÜÁö ¹Ù´ÃÀÇ ±ÜÈû¸¸À¸·Î ¾Ë·¹¸£±â °°Àº ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â Çö»ó°ú °¨º°ÇؾߠÇÑ´Ù.
  
  ³­Ã», Ã»·Â¼Ò½Ç(hearing loss)
  
  Ã»°¢ÀÌ ÀúÇÏ ¶Ç´Â »ó½ÇµÈ »óÅÂ. ¿øÀΰú Á¤µµ´Â ¿©·¯ °¡ÁöÀε¥, ³­Ã»Àº ±× Á¤µµ°¡ °¡Àå ½ÉÇÑ »óÅÂÀÌ´Ù. Ã»°¢ÀÇ Àüµµ°æ·Î¿¡ Àå¾Ö°¡ ÀÖÀ» ¶§ ³­Ã»ÀÌ ÀϾ°í, ±× º´ÅͰ¡ ¿ÜÀ̵µ³ª ÁßÀÌ¿¡ Àִ °ÍÀ» ÀüÀ½³­Ã», ³»ÀÌ¿¡ Àִ °ÍÀ» °¨À½ ³­Ã»À̶ó ÇÏ¿© ±¸ºÐÇÑ´Ù. ¶Ç º´ÅÍÀÇ ÀÚ¸®¸¦ ¸í½ÃÇÏ¿© ÁßÀ̼º ³­Ã»À̳ª ¹Ì·Î¼º ³­Ã» µîÀ¸·Î ¼¼ºÐÇϱ⵵ ÇÑ´Ù.
¿µ¹® stool guaiac test ÇÑ±Û ´ëº¯ ±¸¾ÆÀÌ¾Ç °Ë»ç
¼³¸í   
  ´ëº¯³»¿¡ ÀÖÀ» ¼ö Àִ ÀáÇ÷(´«¿¡ º¸ÀÌÁö ¾Ê´Â ÃâÇ÷)À¯¹«¸¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î, Ç÷±¸³»ÀÇ heme peroxidase¿¡ ÀÇÇØ guaiacÀÌ »êÈ­µÇ´Â ¹ÝÀÀÀ» ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ´Ù. ¹æ¹ýÀº 3Àϰ£¿¡ °ÉÃÄ ÇÑ º¯¿¡¼­ 2±ºµ¥¾¿ Ã¤ÃëÇÏ¿© °Ë»çÇÑ´Ù. À§¾ç¼º ¹ÝÀÀ(°ÅÁþÀ¸·Î Ç÷¾×ÀÌ ÀÖ´Ù°í ³ªÅ¸³ª´Â ¹ÝÀÀ)Àº ½Ä¹° °ú»êÈ­È¿¼Ò¸¦ ÇÔÀ¯Çϰí Àִ ȫ´ç¹«ÀÇ ¼·Ã볪 Ç÷±¸ ¼ººÐÀ» ÇÔÀ¯Çϰí Àִ °í±â ¼·Ã렵¼­ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç, À§À½¼º ¹ÝÀÀ(½ÇÁ¦·Î Ç÷¾×Àº ÀÖÁö¸¸, Ç÷¾×ÀÌ ¾ø´Ù°í ³ªÅ¸³ª´Â ¹ÝÀÀ)Àº È¯¿ø·ÂÀ» °¡Áö°í Àִ ºñŸ¹Î CÀÇ º¹¿ë½Ã ³ªÅ¸³¯ ¼ö ÀÖ´Ù. Æ¯È÷ À§¾ç¼º ¹ÝÀÀÀÌ ¸Å¿ì ÈçÇÏ´Ù.
¿µ¹® Rorschach Test ÇÑ±Û ·Î¸£»þÇÏ °Ë»ç
¼³¸í   
  »ç°íÀå¾Ö¿Í Á¤¼­Àå¾Ö¿¡ ¹Î°¨ÇÑ Åõ»ç°Ë»ç(projective test). °ËÀº»ö°ú ¸î°¡Áö »öÀ¸·Î ÀÌ·ç¾îÁø À×Å©¾ó·è°°Àº µµÇüÀÌ ±×·ÁÁø 10°³ÀÇ Ä«µå¸¦ ÀÌ¿ëÇÑ´Ù. ÇǰËÀÚ¿¡°Ô Ä«µå¸¦ º¸ÀÌ°í º» °Í¿¡ ´ëÇØ ¸»Çϵµ·Ï ÇÑ´Ù. ´ÙÀ½¿¡´Â ¾ó·èÀÇ ¾î´À À§Ä¡°¡ ÇǰËÀÚ°¡ ¸»ÇÑ Áö°¢´ë»óÀ» ¾Ï½ÃÇÏ´ÂÁö Ã£µµ·Ï ÇÑ´Ù. ÇǰËÀÚÀÇ ´äº¯À» ºÐ¼®Çϸ頱×ÀÇ »ç°í¿Í Á¤¼­»óÅ¿¡ ´ëÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ´Ù. 
¿µ¹® Mantoux test ÇÑ±Û ¸ÁÅä¿ì°Ë»ç
¼³¸í   
  ¼Ò¾Æ¿¡ ÁַΠ½Ç½ÃÇϴ °Ë»ç ¹æ¹ýÀ¸·Î, BCGÁ¢Á¾ÈÄ¿¡³ª È¤Àº °áÇÙ±Õ¿¡ ÇѹøÀ̶󵵠³ëÃâµÈ °æ¿ì¿¡ ¾ç¼º¹ÝÀÀÀ¸·Î ³ª¿Â´Ù. ¿ì¸®³ª¶ó¿¡¼­´Â »ýÈÄ 1°³¿ù¿¡ BCG¿¹¹æÁ¢Á¾À» ½ÃÇàÇϹǷΠ´ëºÎºÐ ¾ç¼ºÀ¸·Î ³ª¿À°Ô µÇ³ª, ÀÌ ¿¹¹æÁ¢Á¾À» ¹ÞÁö ¾ÊÀº »óÅ¿¡¼­ ¾ç¼ºÀ¸·Î ³ª¿À¸é, °áÇÙ±ÕÀǠħÅõ¸¦ ÀǽÉÇÒ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endpoint PCR
    ³¡Á¡ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • real time PCR
    ½Ç½Ã°£ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • detection
    1. °ËÃâ 2. ¹ß°ß
  • detection bias
    °ËÃâÄ¡¿ìħ
  • rapid detection method
    ½Å¼Ó°ËÃâ¹ý
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½ºº´
  • viral
    ¹ÙÀÌ·¯½º-
  • viral capsid
    ¹ÙÀÌ·¯½ºÄ¸½Ãµå
  • viral conjunctivitis
    ¹ÙÀÌ·¯½º°á¸·¿°
  • viral disease
    ¹ÙÀÌ·¯½ºº´
  • viral dysentery
    ¹ÙÀÌ·¯½ºÀÌÁú
  • viral hemagglutination
    ¹ÙÀÌ·¯½ºÀûÇ÷±¸ÀÀÁý
  • viral hepatitis
    ¹ÙÀÌ·¯½º°£¿°
  • viral hepatitis type A
    AÇü¹ÙÀÌ·¯½º°£¿°
  • viral hepatitis type B
    BÇü¹ÙÀÌ·¯½º°£¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • detection bias
    °ËÃâÄ¡¿ìħ
  • detection
    °ËÃâ, ¹ß°ß
  • viral conjunctivitis
    ¹ÙÀÌ·¯½º°á¸·¿°
  • viral hepatitis
    ¹ÙÀÌ·¯½º°£¿°
  • viral
    ¹ÙÀÌ·¯½º-
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • test strip
    °Ë»ç¶ì
  • test
    °Ë»ç, ½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • agglutination test
    ÀÀÁý°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • anticholinesterase test
    Ç×Äݸ°¿¡½ºÅ×¶óÁ¦°Ë»ç
  • antiglobulin test
    Çױ۷κҸ°°Ë»ç
  • antimicrobial susceptibility test
    Ç×±ÕÁ¦°¨¼ö¼º°Ë»ç
  • blood test
    Ç÷¾×°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½ºº´
  • viral capsid
    ¹ÙÀÌ·¯½ºÄ¸½Ãµå
  • epidermal-epithelial viral disease
    Ç¥ÇÇ»óÇǹÙÀÌ·¯½ºº´
  • viral disease
    ¹ÙÀÌ·¯½ºº´
  • viral dysentery
    ¹ÙÀÌ·¯½ºÀÌÁú
  • viral hemagglutination
    ¹ÙÀÌ·¯½ºÀûÇ÷±¸ÀÀÁý
  • viral hepatitis
    ¹ÙÀÌ·¯½º°£¿°
  • viral inclusion
    ¹ÙÀÌ·¯½ºÆ÷ÇÔ¹°
  • viral particle
    ¹ÙÀÌ·¯½ºÀÔÀÚ
  • viral pneumonia
    ¹ÙÀÌ·¯½ºÆó·Å
  • viral
    ¹ÙÀÌ·¯½º-
  • detection bias
    ¹ß°ß¹ÙÀ̾
  • carcinogen detection
    ¹ß¾Ï¹°Áú°ËÃâ
  • detection
    °ËÃâ, ¹ß°ß, ±×·Á³¿
  • disease detection
    Áúº´¹ß°ß
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-HCV=antihepatitis C virus
    CÇü°£¿°Ç×ü
  • hepatitis C virus(HCV)
    CÇü °£¿°¹ÙÀÌ·¯½º
  • PCR(polymerase chain reaction)
    ÁßÇÕ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction=PCR
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • acute infectious gastroenteritis =epidemic viral
    ±Þ¼ºÀü¿°¼ºÀ§Àå¿°(¡­îîæøêÖíóæú).
  • acute infectious gastroenteritis =epidermic viral g.
    ±Þ¼º Àü¿°¼º À§Àå¿°(¡­îîæøàõêÖ æú).
  • acute viral hepatitis
    ±Þ¼º ¹ÙÀÌ·¯½º°£¿°(¡­ÊÜæú).
  • acute viral hepatitis
    ±Þ¼º¹ÙÀÌ·¯½º¼º °£¿° (~ÊÜæú)
  • arthropod-borne viral disease
    ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½ºº´
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½º,¾Æº¸¹ÙÀÌ·¯½º
  • hemagglutination, viral
    ¹ÙÀÌ·¯½º Ç÷±¸ÀÀÁý¹ý
  • hepatitis,acute viral
    ±Þ¼º¹ÙÀÌ·¯½º¼º
  • analytical response detection
    ºÐ¼®¹ÝÀÀ°¨Áö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-HCV=antihepatitis C virus
    CÇü°£¿°Ç×ü
  • hepatitis C virus(HCV)
    CÇü °£¿°¹ÙÀÌ·¯½º
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction=PCR
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • analytical response detection
    ºÐ¼®¹ÝÀÀ°¨Áö
  • aneuploidy detection
    À̼ö¹è¼öü °ËÃâ
  • antibody detection
    Ç×ü°ËÃâ
  • antigen detection
    Ç׿ø°ËÃâ
  • carcinogen detection
    ¹ß¾Ï¹°Áú°ËÃâ
  • causative agent detection
    º´¿øÃ¼°ËÃâ
  • cellular detection
    ¼¼Æ÷°ËÃâ
  • detection
    °ËÃâ (Ëþõó)
  • detection
    °ËÃâ(Ëþõó)
  • detection
    °ËÃâ, ¹ß°ß, ±×·Á³¿
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Bachman intradermal test
    ¼±¸ðÃæÇdz»¹ÝÀÀ°Ë»ç
  • bentonite flocculation test
    º¥Å䳪ÀÌÆ®ÀÀÁý°Ë»ç
  • Casoni test
    Æ÷ÃæÇdz»¹ÝÀÀ°Ë»ç
  • circumoval precipitin test (COPT)
    Ãæ¶õÁÖÀ§Ä§°­°Ë»ç
  • intradermal test
    Çdz»¹ÝÀÀ°Ë»ç
  • Mazzotti test
    ¸¶Á¶Æ¼°Ë»ç
  • Montenegro test
    ¸óÅ״ϱ׷ΰ˻ç
  • Sabin-Feldman dye test
    (Åå¼ÒÆ÷ÀÚÃæ) »ö¼Ò¸é¿ª°Ë»ç
  • screening test
    ¼±º°°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • PCr
    (å²) Phosphocreatine
  • viral coat
    ¹ÙÀÌ·¯½º ¿ÜÇÇ(èâù«)
  • viral hepatitis
    ¹ÙÀÌ·¯½º¼º °£¿° (ÊÜæú)
  • viral interference
    ¹ÙÀÌ·¯½º °£¼·(ÊÎàï)
  • viral yield
    ¹ÙÀÌ·¯½º ¼öÀ²(â¥ëÒ)
  • acrolein test
    ¾ÆÅ©·Ñ·¹ÀνÃÇè (ãËúÐ)
  • acute test
    ´Ü·® µ¶¼º½ÃÇè (Ó¤ÕáÔ¸àõãËúÐ)
  • adrenaline tolerance test
    ¾Æµå·¹³¯¸° ºÎÇϽÃÇè(ݶùÃãËúÐ)
  • albustix test
    ¾ËºÎ½ºÆ½½º½ÃÇè(ãËúÐ)
  • Ames test
    ¿¡ÀÓÁî °Ë»ç¹ý
  • antiglobulin consumption test
    Ç×(ù÷)±Û·ÎºÒ¸° ¼Ò¸ð½ÃÇè(á¼ÙÄãËúÐ)
  • antiglobulin test
    Ç×(ù÷)±Û·ÎºÒ¸° ½ÃÇè(ù÷ô÷ãËúÐ)
  • Aschheim-Zondek test
    ¾Æ»þÀÓ-Á¸µ¦ ½ÃÇè(ãËúÐ)
  • Ascoli test
    ¾Æ½ºÄݸ® ½ÃÇè(ãËúÐ)
  • Barfoed's test
    ¹Ù¸£ÆÐµå ½ÃÇè(ãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • viral
    ¹ÙÀÌ·¯½º¼ºÀÇ
  • viral infection
    ¹ÙÀÌ·¯½º°¨¿°
  • pelvis perfusion test(Whitaker test)
    ½Å¿ì°ü·ù°Ë»ç
  • detection
    °ËÃâ, ¹ß°ß, ±×·Á³¿
  • quadrature detection
    ±¸ÀûŽÁö
  • quadrature signal detection
    ±¸Àû½ÅȣŽÁö
  • arm to lung time test
    ÆÈÆó¼øÈ¯½Ã°£½ÃÇè
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • contraction test
    ¼öÃà°Ë»ç
  • double blind test
    ÀÌÁ߸Ͱ˹ý
  • dye dilution test
    »ö¼ÒÈñ¼®½ÃÇè
  • guaiac test
    °úÀ̾׽ÃÇè
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • laboratory test
    °Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SDT sensory detection theory; right sacrotransverse [fetal position] [Lat. sacrodextra transversa]; sign...
PAT Pain Apperception Test; paroxysmal atrial tachycardia; patient; phenylaminotetrazole; physical abili...
HCV Hepatitis C Virus
HCV hepatitis C virus; hog cholera virus
CAT California Achievement Test; capillary agglutination test; catalase; cataract; catecholamine; Childr...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
anti-HCV Antibodies against HCV
anti-HCV Antibodies to HCV
anti-HCV Antibody to HCV
HCV Hepatitis C Viral
AP-PCR Arbitrarily Primed PCR
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigen detection
    Ç׿ø °ËÃâ
  • cellular detection
    ¼¼Æ÷ °ËÃâ
    ¼¼Æ÷ÀÇ Á¸À縦 °ËÃâÇÏ´Â °Í.
  • detection
    °ËÃâ
    °¨Ãß¾îÁ® Àְųª °¡·ÁÁ® ÀÖ´Â ¾î¶² Á¸Àç, »óŸ¦ ¹ß°ß, °ËÃâÇÏ´Â °Í.
  • monoclonal immunoglobulin detection
    ´ÜÀÏ Å¬·Ð ¸é¿ª ±Û·ÎºÒ¸° °ËÃâ
  • mycoplasma detection
    ¹ÌÄÚ Çö󽺸¶ °ËÃâ
  • quadrature signal detection
    ±¸Àû ½ÅÈ£ ŽÁö
  • anti-viral agent
    Ç×¹ÙÀÌ·¯½ºÁ¦
    ¹ÙÀÌ·¯½º¸¦ º´¿øÃ¼·Î ÇÏ´Â Áúº´. Áï, Æ®¶óÄÚ¸¶¡¤¼Ò¾Æ¸¶ºñ
  • arthropod viral disease
    ¾Æ¸£º¸ ¹ÙÀÌ·¯½º Áúȯ, ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½º Áúȯ, ÀýÁöµ¿¹° ¸Å°³¼º ¹ÙÀÌ·¯½º Áúȯ
    µ¿ÀǾî=arbovirus disease.
  • arthropodborne viral fever
    ÀýÁöµ¿¹° ¸Å°³ÀÇ ¹ÙÀÌ·¯½º ¿­
  • chronic slow viral encephalitis
    ¸¸¼º Áö¿¬Çü ¹ÙÀÌ·¯½º¼º ³ú¿°
  • influenzal viral pneumonia
    ÀÎÇ÷翣ÀÚ Æó·Å
    ÀÎÇ÷翣ÀÚ¿¡ °É·Á ÀúÇ×·ÂÀÌ ÀúÇϵǾúÀ» ¶§ ±âµµ¿¡ ÀÖ´ø ¼¼±ÕÀÌ Áõ½ÄµÇ¾î ÀϾ´Â Æó·Å. ÀÌ¿Í °°ÀÌ 2Â÷ °¨¿°À» ÀÏÀ¸Å°´Â ¼¼±ÕÀº Æ÷µµ ±¸±Õ , Æó·Å ±¸±Õ , ¿¬¼â ±¸±Õ , ÀÎÇ÷翣ÀÚ ±Õ , Æó·Å °£±Õ µîÀÌ´Ù. º»ÁõÀÇ ÇÕº´·üÀº À¯Çà¿¡ µû¶ó Å« Â÷°¡ ÀÖÀ¸¸ç ¿¬·ÉÀûÀ¸·Î´Â ³ëÀÎÀÇ °æ¿ì¿¡ ³ô´Ù. Áõ¼¼´Â ÀÎÇ÷翣ÀÚÀÇ °í¿­ÀÌ 2¡­3ÀÏÀÌ µÇ¾îµµ ³»¸®Áö ¾Ê°í, ¶Ç´Â ÀÏ´Ü ³»·È´ø ¿­ÀÌ ´Ù½Ã »ó½ÂÇϸ鼭 È£Èí °ï¶õµµ ´õ¿í ½ÉÇØÁø´Ù. ÀÔ¼úÀ̳ª ¼Õ³¡Àº Â÷°¡¿öÁö°í ûÀÚ»öÀ» ¶í´Ù. ±âħ°ú ´ãµµ ¸¹À¸¸ç, ÈäºÎÀÇ Ã»Áø , ŸÁøÀ̳ª X¼± °Ë»ç¿¡¼­ Æó·ÅÀÇ ¼Ò°ßÀÌ Áõ¸íµÈ´Ù. Ä¡·á´Â 2Â÷ °¨¿°±Õ¿¡ ÀûÀÀµÇ´Â Ç×»ý ¹°ÁúÀ» ¾²´Â ¿Ü¿¡ ÀÏ¹Ý Æó·ÅÀÇ Ä¡·á¿¡ ÁØÇÑ´Ù. ³ëÀÎÀÇ °æ¿ì´Â »ç¸Á·üÀÌ ³ôÀ¸¸ç, ¶ÇÇÑ ÀÎÇ÷翣ÀÚ·Î »ç¸ÁÇÏ´Â »ç¶÷ÀÇ ¾à 80 %´Â Æó·ÅÀÇ ÇÕº´ ¶§¹®ÀÌ´Ù.
  • viral antibody
    ¹ÙÀÌ·¯½º Ç×ü
  • viral arthritis
    ¹ÙÀÌ·¯½º °üÀý¿°, ¹ÙÀÌ·¯½º¼º °üÀý¿°
  • viral capsid antigen
    ¹ÙÀÌ·¯½º ĸ½Ãµå Ç׿ø, ¹ÙÀÌ·¯½º¼º ĸ½Ãµå Ç׿ø
  • viral demonstration
    ¹ÙÀÌ·¯½º Áõ¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
HCV A non-A, non-B RNA virus causing post-transfusion hepatitis; it appears to be a member of the family Flaviviridae.
(05 Mar 2000)
PCR test <investigation> A very sensitive test that measures the presence or amount of RNA or DNA of a specific organism or virus (for example: HIV or CMV) in the blood or tissue. PCR tests such as HoffmannLa Roche's HIV RT PCR are being used to gauge HIV disease progression and the effect of particular treatments on HIV infection.
(09 Oct 1997)
PCR <molecular biology, technique> The first practical system for in vitro amplification of DNA and as such one of the most important recent developments in molecular biology.
Two synthetic oligonucleotide primers, which are complementary to two regions of the target DNA (one for each strand) to be amplified, are added to the target DNA (that need not be pure), in the presence of excess deoxynucleotides and Taq polymerase, a heat stable DNA polymerase. In a series (typically 30) of temperature cycles, the target DNA is repeatedly denatured (around 90_C), annealed to the primers (typically at 50-60_C) and a daughter strand extended from the primers (72_C). As the daughter strands themselves act as templates for subsequent cycles, DNA fragments matching both primers are amplified exponentially, rather than linearly.
The original DNA need thus be neither pure nor abundant and the polymerase chain reaction has accordingly become widely used not only in research, but in clinical diagnostics and forensic science.
Acronym: PCR
(14 Oct 1997)
reverse transcriptase PCR A technique used to amplify RNA targets. The specimen containing the target RNA (e.g., HIV-1 RNA, Hepatitis C Virus RNA) is subjected to reverse transcription to make complementary DNA (cDNA), which is then, in turn, amplified by PCR.
Acronym: RT-PCR
(05 Mar 2000)
differential display PCR Method of image formation in the light microscope based on the method proposed by Nomarski (though strictly speaking all forms of optical microscopy rely to a greater or lesser extent on differential interference). The light beam is split by a Wollaston prism in the condenser, to form slightly divergent beams polarized at right angles. One passes through the specimen (and is retarded if the refractive index is greater) and one through the background nearby: the two are recombined in a second Wollaston prism in the objective and interfere to form an image. The image is spuriously three dimensional the nucleus, for example: appears to stand out above the cell (or be hollowed out) because it has a higher refractive index than the cytoplasm. The Nomarski system has the advantage that there is no phase halo, but the contrast is low and image formation with crowded cells is poor because the background does not differ from the specimen.
(18 Nov 1997)
cancer detection Methods used to find cancer in persons who may or may not have symptoms. Symptoms of cancer are abnormal sensations or conditions that persons can notice that are a result of the cancer. It is important to your doctor for regular checkups and not wait for problems to occur. But you should also know that the following symptoms may be associated with cancer: changes in bowel or bladder habits, a sore that does not heal, unusual bleeding or discharge, thickening or lump in the breast or any other part of the body, indigestion or difficulty swallowing, obvious change in a wart or mole, or nagging cough or hoarseness. These symptoms are not always a sign of cancer. They can also be caused by less serious conditions. Only a doctor can make a diagnosis. It is important to see a doctor if you have any of these symptoms. Don't wait to feel pain. Early cancer often does not cause pain.
(12 Dec 1998)
recruitment detection <otolaryngology, technique> Tests for measuring loudness recruitment.
(04 Jul 1999)
glaucoma detection You may know of the air puff test or other tests used to measure eye pressure in an eye examination. But, this test alone cannot detect glaucoma. Glaucoma is found most often during an eye examination through dilated pupils after drops are put into the eyes during the exam to enlarge the pupils. This allows the eye care professional to see more of the inside of the eye to check for signs of glaucoma.
(12 Dec 1998)
heterozygote detection Identification of genetic carriers for a given trait.
(12 Dec 1998)
signal detection (psychology) A theory of psychophysics which characterises not only the acuity of an individual's discrimination but also the psychological factors that bias his judgment.
(12 Dec 1998)
substance abuse detection Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.
(12 Dec 1998)
detection Act of detecting, discovery, the laying open of what was concealed or hidden or of what tends to elude observation.
(18 Nov 1997)
ovulation detection Methods for recognition of the occurrence of ovulation.
(12 Dec 1998)
estrus detection Methods for recognition of the state of estrus.
(12 Dec 1998)
lie detection Ascertaining of deception through detection of emotional disturbance as manifested by changes in physiologic processes usually using a polygraph.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • viral
    ¹ÙÀÌ·¯½ºÀÇ;¿©°ú¼º º´¿øÃ¼ÀÇ;¹ÙÀÌ·¯½º¼ºÀÇ
  • detection
    ¹ß°ß;´çÁö
  • detection station
    (ÇÙ½ÇÇèÀÇ)°¨½Ã¼Ò
  • test
    ½ÃÇè,½ÃÇèÇÏ´Ù
  • Binet Simon test
    Áö³×½Ã¸ù½Ä Áö´É °Ë»ç¹ý
  • Dick test
    (ÀÇ)µñ Å×½ºÆ®(¼ºÈ«¿­ ÇǺΠ½ÃÇè)
  • Kline test
    Ŭ¶óÀÎ ½ÃÇè(¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀ)
  • New Test.
    New Testament
  • Partial Test Ban Treaty
    ºÎºÐÀû ÇÙ½ÇÇè ±ÝÁö Á¶¾à
  • Rorschach test
    ·Î¸£»þÇÏ Å×½ºÆ®(À×Å©ÀÇ ¾ó·è°£Àº ¹«ÀǹÌÇÑ ¹«´Ì¸¦ ÇØ¼®½ÃÄÑ »ç¶÷ÀÇ ¼º°ÝµîÀ» ¾Ë¾Æ³»´Â °Ë»ç)
  • Wassermann test
    ¹Ù¼­¸¸ °Ë»ç(¹ÝÀÀ);¸Åµ¶ÀÇ Ç÷û Áø´Ü
  • achievement test
    Çз°˻ç
  • acid test
    »ê½ÃÇè;¾ö¹ÐÇѽÃÇè
  • alpha test
    Áö´ÉÅ×½ºÆ®
  • blood test
    Ç÷¾×°Ë»ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á